Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315633) titled 'An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer' on Dec. 18, 2025.
Study Type: Observational
Primary Sponsor: University Hospital, Ghent
Condition:
Hepatocellular Carcinoma (HCC)
Liver Cancer, Adult
Liver Cancer
Intervention:
Device: Endovascular treatment
Recruitment Status: Recruiting
Date of First Enrollment: September 23, 2025
Target Sample Size: 80
Countries of Recruitment:
Belgium
To know more, visit https://clinicaltrials.gov/study/NCT07315633
Published by HT Digital Content Services with permission from Health ...